China

CIRS RD Briefing 56: Understanding the dynamics of China’s regulatory environment

Changes have occurred in the organisation and procedural activities of the China Food and Drug Administration (CFDA) and the Centre for Drug Evaluation (CDE). Initiatives that were designed to [...]

2022-05-04T09:06:07+00:00June 1st, 2015|Tags: , , |
Go to Top